LAB150
“Toronto Innovation Acceleration Partners (TIAP)”
The funder does not disclose this information
Maximum Eligible Amount
In-kind
Fund Type
The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products.
LAB150 helps innovators access a wide range of drug discovery and development capabilities, including: Target Identification and Validation; Screening and Hit Identification; Testing Novel Therapeutics in In-Vivo Models; Drug Metabolism and Pharmacokinetics; Medicinal Chemistry; Proteomics and Metabolomics.
Log in with Google